Oral cancer and ACE2 receptor of SARS-CoV-2
- PMID: 32713810
- PMCID: PMC7373056
- DOI: 10.1016/j.oraloncology.2020.104920
Oral cancer and ACE2 receptor of SARS-CoV-2
Keywords: COVID-19; Oral squamous cell carcinoma; Renin-angiotensin system.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559. doi: 10.1164/rccm.202003-0693LE. Am J Respir Crit Care Med. 2020. PMID: 32329629 Free PMC article. No abstract available.
References
-
- Fraga C.A.C., Farias L.C., Jones K.M., Paula A.M.B., Guimarães A.L.S. Angiotensin-converting enzymes (ACE and ACE2) as potential targets for malignant epithelial neoplasia: review and bioinformatics analyses focused in oral squamous cell carcinoma. Protein Pept Lett. 2017;24(9):1–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
